Cita APA

He, M., Souza, E., Matvekas, A., Crass, R. L., & Pai, M. P. (2021). Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model. Antimicrob Agents Chemother.

Citación estilo Chicago

He, Miao, Ernane Souza, Aleksas Matvekas, Ryan L. Crass, y Manjunath P. Pai. "Alteration in Acute Kidney Injury Potential With the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model." Antimicrob Agents Chemother 2021.

Cita MLA

He, Miao, et al. "Alteration in Acute Kidney Injury Potential With the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model." Antimicrob Agents Chemother 2021.